IHS Chemical Week

Regions :: Western Europe :: Germany

Bayer completes acquisition of Teva’s US animal health business

12:55 AM MST | January 4, 2013 | Deepti Ramesh

Bayer HealthCare says it has received the necessary regulatory approval from the FTC to complete the previously announced acquisition of the US-based animal health business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel). The acquisition includes a manufacturing site at St. Joseph, MO, and about 300 employees. Bayer had announced plans for the acquisition in September 2012. Bayer is paying up to $145 million for the acquisition, which includes an upfront payment of $60 million and a total of $85 million in milestone payments, which are linked to the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa